Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMHUBT5)

Drug Name
3-Carbazol-9-yl-propionic acid Drug Info
Synonyms
6622-54-4; 3-(9H-carbazol-9-yl)propanoic acid; 3-carbazol-9-ylpropanoic acid; CHEMBL184817; Carbazole-9-propionic acid; NSC400; Carbazol-N-propionsaure; AC1Q75LO; AC1Q5WE7; TimTec1_004366; Oprea1_037143; Oprea1_183633; SCHEMBL150033; 9H-Carbazole-9-propionic acid; AC1L56H9; DTXSID30277021; 3-(carbazol-9-yl)propanoic acid; NSC-400; MolPort-000-474-043; 3-(Carbazol-9-yl)propionic acid; HMS1546G10; NSC54636; ZINC1841595; STK387004; BDBM50152856; 7615AE; BBL007862; SBB010078
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
219301
CAS Number
CAS 6622-54-4
TTD Drug ID
DMHUBT5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Fatty acid-binding protein 4 (FABP4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]

References

1 Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.
2 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.